Sponsor Pipeline

Olympus Corporation of the Americas Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
1
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-04 NCT04757116
Post-Market Study to Assess iTind Safety in Comparison to UroLift		 Primary endpoint(s) modified
2026-08-04 NCT04757116
Post-Market Study to Assess iTind Safety in Comparison to UroLift		 Enrollment increased: 206 -> 256 participants
2026-08-04 NCT04757116
Post-Market Study to Assess iTind Safety in Comparison to UroLift		 date change Primary completion pushed: 2026-06-30 -> 2027-07-15
2026-08-04 NCT04757116
Post-Market Study to Assess iTind Safety in Comparison to UroLift		 date change Completion moved earlier: 2031-12-31 -> 2030-05-31
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-20 NCT07715240 The HANAROSTENT® Multi-Hole™ Biliary Stent is Indicated for Use in the Palliative… Not Yet Recruiting
Active Trials by Phase
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT06592820 Endoscopic Ultrasound Shear Wave Elastography Study MASLD Recruiting
NCT04302272 STRIVE Post-Market Registry Study Emphysema Recruiting
NCT04757116 Post-Market Study to Assess iTind Safety in Comparison to UroLift Benign Prostatic Hyperplasia (BPH) Recruiting
NCT07715240 The HANAROSTENT® Multi-Hole™ Biliary Stent is Indicated for Use in the Palliative… Biliary Strictures Caused by Malignant Neoplasms Not Yet Recruiting
Disease Areas
NASH / MASH (1)
Get alerts when Olympus Corporation of the Americas's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free